A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of R-Verapamil in the Prophylaxis of Episodic Cluster Headache
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2018
Price : $35 *
At a glance
- Drugs R-verapamil (Primary)
- Indications Cluster headache
- Focus Therapeutic Use
- Sponsors Center Laboratories
- 09 Apr 2018 Status changed from active, no longer recruiting to discontinued.
- 24 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 24 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.